Works matching IS 0008543X AND DT 2013 AND VI 119

Results: 827
    1
    2
    3

    Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.

    Published in:
    2013
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Nanjo, Shigeki;
    • Fujita, Shiro;
    • Kaji, Reiko;
    • Imai, Yukihiro;
    • Monden, Kazuya;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Tachikawa, Ryo;
    • Tomii, Keisuke;
    • Kunimasa, Kei;
    • Iwasaku, Masahiro;
    • Nishiyama, Akihiro;
    • Ishida, Tadashi;
    • Nishimura, Yoshihiro
    Publication type:
    Journal Article
    4

    Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4231, doi. 10.1002/cncr.28331
    By:
    • Agarwal, Atin;
    • Chang, George J.;
    • Hu, Chung‐Yuan;
    • Taggart, Melissa;
    • Rashid, Asif;
    • Park, In J.;
    • You, Y. Nancy;
    • Das, Prajnan;
    • Krishnan, Sunil;
    • Crane, Christopher H.;
    • Rodriguez‐Bigas, Miguel;
    • Skibber, John;
    • Ellis, Lee;
    • Eng, Cathy;
    • Kopetz, Scott;
    • Maru, Dipen M.
    Publication type:
    Article
    5
    6
    7

    Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4325, doi. 10.1002/cncr.28364
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Nanjo, Shigeki;
    • Fujita, Shiro;
    • Kaji, Reiko;
    • Imai, Yukihiro;
    • Monden, Kazuya;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Tachikawa, Ryo;
    • Tomii, Keisuke;
    • Kunimasa, Kei;
    • Iwasaku, Masahiro;
    • Nishiyama, Akihiro;
    • Ishida, Tadashi;
    • Nishimura, Yoshihiro
    Publication type:
    Article
    8

    Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4341, doi. 10.1002/cncr.28346
    By:
    • Giacomazzi, Juliana;
    • Selistre, Simone G.;
    • Rossi, Cristina;
    • Alemar, Barbara;
    • Santos‐Silva, Patricia;
    • Pereira, Fernando S.;
    • Netto, Cristina B.;
    • Cossio, Silvia L.;
    • Roth, Daniela E.;
    • Brunetto, Algemir L.;
    • Zagonel‐Oliveira, Marcelo;
    • Martel‐Planche, Ghyslaine;
    • Goldim, Jose R.;
    • Hainaut, Pierre;
    • Camey, Suzi A.;
    • Ashton‐Prolla, Patricia
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4268, doi. 10.1002/cncr.28365
    By:
    • Limaye, Sewanti Atul;
    • Haddad, Robert I.;
    • Cilli, Fiona;
    • Sonis, Stephen T.;
    • Colevas, A. Dimitrios;
    • Brennan, Michael T.;
    • Hu, Kenneth S.;
    • Murphy, Barbara A.
    Publication type:
    Article
    26
    27
    28
    29
    30

    Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

    Published in:
    2013
    By:
    • Fangusaro, Jason;
    • Gururangan, Sridharan;
    • Poussaint, Tina Young;
    • McLendon, Roger E;
    • Onar-Thomas, Arzu;
    • Warren, Katherine E;
    • Wu, Shengjie;
    • Packer, Roger J;
    • Banerjee, Anu;
    • Gilbertson, Richard J;
    • Jakacki, Regina;
    • Gajjar, Amar;
    • Goldman, Stewart;
    • Pollack, Ian F;
    • Friedman, Henry S;
    • Boyett, James M;
    • Kun, Larry E;
    • Fouladi, Maryam
    Publication type:
    journal article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11).

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 23, p. 4180, doi. 10.1002/cncr.28343
    By:
    • Fangusaro, Jason;
    • Gururangan, Sridharan;
    • Poussaint, Tina Young;
    • McLendon, Roger E.;
    • Onar‐Thomas, Arzu;
    • Warren, Katherine E.;
    • Wu, Shengjie;
    • Packer, Roger J.;
    • Banerjee, Anu;
    • Gilbertson, Richard J.;
    • Jakacki, Regina;
    • Gajjar, Amar;
    • Goldman, Stewart;
    • Pollack, Ian F.;
    • Friedman, Henry S.;
    • Boyett, James M.;
    • Kun, Larry E.;
    • Fouladi, Maryam
    Publication type:
    Article
    48
    49
    50

    Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 23, p. 4196, doi. 10.1002/cncr.28329
    By:
    • Cai, Sophie;
    • Hong, Theodore S.;
    • Goldberg, Saveli I.;
    • Fernandez‐del Castillo, Carlos;
    • Thayer, Sarah P.;
    • Ferrone, Cristina R.;
    • Ryan, David P.;
    • Blaszkowsky, Lawrence S.;
    • Kwak, Eunice L.;
    • Willett, Christopher G.;
    • Lillemoe, Keith D.;
    • Warshaw, Andrew L.;
    • Wo, Jennifer Y.
    Publication type:
    Article